In July 2024, the U.S. Centers for Medicare and Medicaid (CMS) granted Category B coverage for certain expenses incurred by ...

The closely watched trial of a man accused of drugging his wife and inviting others to rape her while she lay unconscious at ...

Glaukos Corporation GKOS recently announced that the second Phase 3 confirmatory pivotal trial for Epioxa, the company’s next ...

US-based 4C Medical has enrolled the first patients in a pivotal trial for its transcatheter mitral valve replacement (TMVR) ...

LTR Pharma’s pivotal trial for its novel intranasal formulation SPONTAN demonstrates it outperforms traditional oral erectile ...

The company is preparing for the Phase 3 study start in the first quarter of 2025BRISBANE, Calif., Oct. 10, 2024 (GLOBE ...

has prompted the biotech to seek discussions with regulators about the design of a pivotal trial. The new results, presented at the Association for Research in Vision and Ophthalmology (ARVO ...

Corcept could be significantly undervalued based on long term potential growth and science-based innovation. Find out why ...

Amplitude Vascular Systems enrolled the first patient(s) in the U.S. pivotal trial for its intravascular lithotripsy (IVL) ...

Microbot Medical Inc. recently announced an acceleration of patient enrollment for the ACCESS-PVI human clinical trial of the Li ...

“It takes significant dedication and a lot of teamwork to take an innovative solution to treat MR from ideation to a global pivotal trial. We are very grateful for such strong support from key opinion ...

The results come from a phase IIa safety and tolerability study. The drug’s developers say they are working with regulatory ...